高分辨率MRI在评估他类药物对症状性内动脉样硬化的疗效时的应用
Juan Huang1, Cong Liu2, Sheng Jiao1
1Department of Radiology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
European radiology
|July 19, 2024
概括
类药物有效地减少斑块负担,稳定内动脉样硬化斑块. 高分辨率的MRI证实了这些斑块变化,有效性受到使用时间和患者因素的影响.
科学领域:
- 神经学 神经学
- 心脏病学 心脏病学
- 放射学 放射学是一门学科.
背景情况:
- 症状的内动脉样硬化斑块对复发性中风具有显著的风险.
- 类药物广泛用于降低心血管风险,但它们对内斑块特征的直接影响需要进一步研究.
研究的目的:
- 评估他类药物治疗在减轻负担和稳定内动脉样硬化斑块方面的疗效.
- 使用高分辨率的3.0特斯拉MR血管壁成像 (HR-MRI) 来评估斑块变化.
主要方法:
- 通过HR-MRI确认的48名患有症状的内动脉样硬化斑块的患者的回顾性分析.
- 患者接受了他类药物治疗,至少3个月后随访HR-MRI.
- 统计分析包括配对样本t测试,威尔科克森等级总和测试和多变量线性回归.
主要成果:
- 长期的他类药物治疗 (>6个月) 显著减少了斑块长度,壁厚,斑块负担,光线狭窄和斑块增强.
- 具有良好的脂质控制的患者也观察到类似的改善.
- 与减少斑块负担相关的因素包括年轻年龄,较低的BMI和高血压;减少斑块增强与较低的BMI,高血压和更长的他类药物持续时间有关.
结论:
- HR-MRI是评估他类药物对内动脉样硬化斑块的疗效的一个有价值的工具.
- 已经证明,他类药物可以减少斑块负担,并促进斑块稳定.
- 立方体疗效受到治疗持续时间,脂质控制和患者特定因素的影响,如年龄,BMI和高血压.
相关概念视频
01:21Imaging Studies for Cardiovascular System IV: CMRI
541
Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
541
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
973
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
973
01:26Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741